SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) July 28, 2004
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-16789 |
|
04-3565120 |
|
(State
or other jurisdiction of |
|
(Commission file number) |
|
(IRS
Employer Identification |
|
|
|
|
|
|
|
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 |
||||
|
(Address of principal executive offices) |
||||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (781) 647-3900 |
||||
|
|
|
|
|
|
|
Not Applicable |
||||
|
(Former name or former address, if changed since last report) |
||||
ITEM 7. EXHIBITS
(c) Exhibits: The following exhibit is furnished with this report:
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated July 28, 2004, entitled “Inverness Medical Innovations Announces Second Quarter 2004 Results” |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 28, 2004, Inverness Medical Innovations, Inc. issued a press release entitled “Inverness Medical Innovations Announces Second Quarter 2004 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INVERNESS MEDICAL INNOVATIONS, INC. |
||
|
|
|
||
|
|
BY: |
/s/ Christopher J. Lindop |
|
|
|
|
Christopher J. Lindop |
|
|
|
|
|
|
|
Dated: July 28, 2004 |
|
|
|
3
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release dated July 28, 2004, entitled “Inverness Medical Innovations Announces Second Quarter 2004 Results” |
4